![](../images/joint1.gif)
|
![](../images/castle.jpg) |
![](../images/joint2.gif)
|
![](../images/scotadd.gif)
|
![](../images/purpleline.gif)
|
Plenary
Sessions
Monday, 23 April - Friday, 27 April
Last updated 20 January 2009
|
New
Contrast Agents
Monday, 23 April
Jeffrey L. Evelhoch, Arend Heerschap, Michal Neeman, Pottumarthi V. Prasad, Organizers |
Educational Objectives:
Upon completion of this session, participants should be able to:
- List examples of specific molecular targets
which fluorescent probes can be used to identify and/or quantify;
- Identify approaches that are being used to
develop MR contrast agents which can be used to identify and/or quantify specific
molecular targets;
- Explain how a MR contrast agent can be
activated by an enzyme;
- Compare and contrast the advantages and
disadvantages of fluorescent probes and MR contrast agents for identifying specific
molecular targets;
- Predict what role targeted MR contrast
agents will play in future clinical practice.
|
|
09:00 |
Contrast with
Fluorescent Tubes
Stephen R. Adams, University of California, San Diego, California, USA |
09:25 |
Affinity-Targeted
Contrast Agents
Samuel A. Wickline, Barnes Jewish Hospital, St. Louis, Missouri, USA |
09:50 |
Activated Contrast
Agents
Thomas J. Meade, California Institute of Technology, Pasadena, California, USA |
|
Challenges
to MRI
Tuesday, 24 April
Michael H. Buonocore, Thomas Kahn, Roderic I. Pettigrew, and J. Thomas Vaughan, Organizers |
Educational Objectives:
With regard to ultrasound, X-ray computerized tomography, and PET techniques, upon
completion of this session, participants should be able to:
- Describe the theory and operation of each
modality;
- Describe the principal capabilities of each
modality in the clinical setting;
- List significant biomedical questions that
are uniquely answered by each modality;
- List current areas of research and
development in each modality;
- Identify apparent strengths and weaknesses
of each modality relative to MR.
|
|
08:15 |
Computed Tomography -
Faster and Ever Faster
Willi A. Kalender, Friedrich-Alexander University, Erlangen, Germany |
08:40 |
PET - The Future Will
Lie in Improved Sensitivity and Specificity
Terry Jones, Hammersmith Hospital, London, England, UK |
09:05 |
Ultrasound - From
Coarse Screening to 3D Power Color
Thomas R. Nelson, University of California, San Diego, California, USA |
|
MR
and Aging
Wednesday, 25 April
Jorg F. Debatin, Mathias Hoehn, and Chrit T. Moonen, Organizers |
Educational Objectives:
Upon completion of this session, participants should be able to:
- Evaluate the economic and medical
implications for MRI of an aging population;
- Identify technical approaches to enhance
patient throughput;
- Describe how the normal "aged"
brain differs from a normal "young" brain;
- Use various MR techniques to detect disease
processes associated with aging in the brain, the cardiovascular system, and the
musculoskeletal system.
|
|
08:15 |
The Aging Population
- A Challenge to MRI?
Adrian Dixon, University of Cambridge, Cambridge, England, UK |
08:40 |
The Aging Brain
Nicholas C. Fox, University College London, London, England, UK |
09:05 |
The Aging Body
Robert J. Herfkens, Stanford University, Stanford, California, USA |
|
Multinuclear
MR
Thursday, 26 April
John R. Griffiths, Arend Heerschap, Sarah J. Nelson, and J. Thomas Vaughan, Organizers |
Educational Objectives:
Upon completion of this session, participants should be able to:
- Describe the role of multinuclear MR in
understanding, diagnosing, and treating disease;
- List three diseases on which multinuclear MR
is having a major impact;
- Evaluate the current and future role of
high-field multinuclear MRS, especially regarding exceptional data from high fields;
- Explain the hardware adjustments required
for imaging hyperpolarized gases and describe the role of hyperpolarized gases in
assessing pulmonary diseases processes.
|
|
08:15 |
High Field
Multinuclear MRS: The Challenge is Paying Off
Michael Garwood, University of Minnesota, Minneapolis, Minnesota, USA |
08:40 |
Multinuclear Studies
on Metabolism in Disease
Douglas L. Rothman, Yale University School of Medicine, New Haven, Connecticut, USA |
09:05 |
Hyperpolarized Gas
Methods in the Clinic
Hans-Ulrich Kauczor, University of Mainz, Mainz, Germany |
|
|
Current and Future Roles for fMRI
Friday, 27 April
Linda Chang, Peter Jezzard, Denis Le Bihan, and Eric C. Wong, Organizers |
Educational
Objectives: Upon completion of this session, participants should be able
to:
- Explain new developments in quantitative
fMRI;
- Define the requirements for successful
clinical fMRI;
- Describe the potential contributions of fMRI
to neuroscience applications;
- Identify emerging techniques and
applications of MRI.
|
|
08:15 |
Mapping
Task-Induced Changes in Cerebral Oxygen Metabolism
Richard Hoge, Massachusetts General Hospital, Boston, Massachusetts, USA |
08:40 |
Clinical
Applications of fMRI
Keith Thulborn, University of Illinois, Chicago, Illinois, USA |
09:05 |
Advancing
our Knowledge of Brain Function and Structure
Karl Zilles, Heinrich-Heine University, Dusseldorf, Germany |
|